Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
18.48
+0.21 (1.15%)
At close: Jun 26, 2025, 4:00 PM
18.48
0.00 (0.00%)
After-hours: Jun 26, 2025, 4:04 PM EDT

Sabra Health Care REIT Statistics

Total Valuation

SBRA has a market cap or net worth of $4.40 billion. The enterprise value is $6.73 billion.

Market Cap 4.40B
Enterprise Value 6.73B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, after market close.

Earnings Date Aug 6, 2025
Ex-Dividend Date May 16, 2025

Share Statistics

SBRA has 237.94 million shares outstanding. The number of shares has increased by 1.90% in one year.

Current Share Class 237.94M
Shares Outstanding 237.94M
Shares Change (YoY) +1.90%
Shares Change (QoQ) +0.27%
Owned by Insiders (%) 1.59%
Owned by Institutions (%) 96.50%
Float 234.07M

Valuation Ratios

The trailing PE ratio is 30.87 and the forward PE ratio is 25.42. SBRA's PEG ratio is 2.76.

Price/FFO Ratio 13.10
Price/AFFO Ratio n/a
PE Ratio 30.87
Forward PE 25.42
PS Ratio 5.96
Forward PS 5.78
PB Ratio 1.61
P/TBV Ratio 1.63
P/FCF Ratio n/a
P/OCF Ratio 12.92
PEG Ratio 2.76
Financial Ratio History

Enterprise Valuation

EV / Earnings 47.81
EV / Sales 9.34
EV / EBITDA 15.58
EV / EBIT 25.23
EV / FCF n/a

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.89.

Current Ratio 0.85
Quick Ratio 0.36
Debt / Equity 0.89
Debt / EBITDA 5.55
Debt / FCF n/a
Interest Coverage 2.35

Financial Efficiency

Return on equity (ROE) is 5.15% and return on invested capital (ROIC) is 3.22%.

Return on Equity (ROE) 5.15%
Return on Assets (ROA) 3.14%
Return on Invested Capital (ROIC) 3.22%
Return on Capital Employed (ROCE) 5.20%
Revenue Per Employee $14.40M
Profits Per Employee $2.82M
Employee Count 50
Asset Turnover 0.14
Inventory Turnover n/a

Taxes

In the past 12 months, SBRA has paid $965,000 in taxes.

Income Tax 965,000
Effective Tax Rate 0.68%

Stock Price Statistics

The stock price has increased by +23.54% in the last 52 weeks. The beta is 0.81, so SBRA's price volatility has been lower than the market average.

Beta (5Y) 0.81
52-Week Price Change +23.54%
50-Day Moving Average 17.83
200-Day Moving Average 17.70
Relative Strength Index (RSI) 57.53
Average Volume (20 Days) 2,488,869

Short Selling Information

The latest short interest is 19.26 million, so 8.10% of the outstanding shares have been sold short.

Short Interest 19.26M
Short Previous Month 20.54M
Short % of Shares Out 8.10%
Short % of Float 8.23%
Short Ratio (days to cover) 7.13

Income Statement

In the last 12 months, SBRA had revenue of $720.25 million and earned $140.76 million in profits. Earnings per share was $0.60.

Revenue 720.25M
Gross Profit 487.83M
Operating Income 266.72M
Pretax Income 54.12M
Net Income 140.76M
EBITDA 432.05M
EBIT 266.72M
Earnings Per Share (EPS) $0.60
Full Income Statement

Balance Sheet

The company has $37.89 million in cash and $2.40 billion in debt, giving a net cash position of -$2.36 billion or -$9.94 per share.

Cash & Cash Equivalents 37.89M
Total Debt 2.40B
Net Cash -2.36B
Net Cash Per Share -$9.94
Equity (Book Value) 2.70B
Book Value Per Share 11.36
Working Capital -15.97M
Full Balance Sheet

Cash Flow

Operating Cash Flow 338.01M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 67.73%, with operating and profit margins of 37.03% and 19.54%.

Gross Margin 67.73%
Operating Margin 37.03%
Pretax Margin 19.68%
Profit Margin 19.54%
EBITDA Margin 59.99%
EBIT Margin 37.03%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of $1.20, which amounts to a dividend yield of 6.49%.

Dividend Per Share $1.20
Dividend Yield 6.49%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 200.43%
Buyback Yield -1.90%
Shareholder Yield 4.64%
Earnings Yield 3.22%
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SBRA is $19.71, which is 6.66% higher than the current price. The consensus rating is "Buy".

Price Target $19.71
Price Target Difference 6.66%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 7.44%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5